Danish pharmaceutical company Lundbeck Wednesday posted a higher than expected quarterly net profit, helped by the expansion of an alliance with Japan's Otsuka and the divestment of a US portfolio of non-core products.
Medications May 01, 2013 | not rated yet | 0
U.S. health regulators will require generic versions of the best-selling painkiller OxyContin to include recent formulation changes designed to make the pill harder to abuse.
Medications Apr 16, 2013 | not rated yet | 1
(AP)—The Food and Drug Administration will hold a meeting in June to reassess the safety of GlaxoSmithKline's former blockbuster diabetes drug Avandia.
Medications Apr 12, 2013 | not rated yet | 0
(Medical Xpress)—Companies may be misusing the drug patenting system in order to gain control over high-cost drugs in Australia, research from the Melbourne Law School has found.
Medications Apr 10, 2013 | 5 / 5 (1) | 0 |
The U.S. Justice Department is investigating drug maker Sanofi's disclosures to the Food and Drug Administration about different responses to its blockbuster blood thinner Plavix.
Medications Mar 11, 2013 | not rated yet | 0
Pfizer Inc.'s fourth-quarter profit more than quadrupled, despite competition from generic drugs hurting sales of Lipitor and other medicines, because of a $4.8 billion gain from selling its nutrition business. ...
Other Jan 29, 2013 | not rated yet | 0
The Food and Drug Administration says it has approved the anticlotting drug Eliquis, developed by Bristol-Myers Squibb Co. and Pfizer Inc. It's a potential blockbuster drug in a new category of medicines to prevent strokes ...
Medications Dec 28, 2012 | not rated yet | 0
Regulators in Japan have approved sales of an anticlotting drug called Eliquis, developed by Bristol-Myers Squibb Co. and Pfizer Inc., that's a potential blockbuster in a new category of medicines to prevent strokes and heart ...
Medications Dec 26, 2012 | not rated yet | 0
When Linda Tuttle was diagnosed with breast cancer, she never imagined her experience would inspire her colleagues to design new treatments to tackle the disease.
Cancer Oct 02, 2012 | 5 / 5 (1) | 0 |
US regulators were expected to decide Tuesday whether to approve the second new anti-obesity drug in 13 years, Qnexa, which studies have shown may help some people lose up to 10 percent of their body weight.
Medications Jul 17, 2012 | not rated yet | 0
(HealthDay) -- The blockbuster drug Plavix (clopidogrel), used to prevent clotting in some heart patients, will go off patent in the United States on Thursday, making it considerably more affordable.
Medications May 15, 2012 | not rated yet | 0
It's Sunday lunchtime in Las Vegas and Justin looks like he wants to curl up and die. He has a monster hangover after drinking for two days solid. But help, he hopes, is at hand.
Other Apr 24, 2012 | 5 / 5 (1) | 1
An experimental blood thinning drug made by the pharmaceutical giant Merck may reduce the risk of dying from a heart attack but also boosts the danger of internal bleeding, researchers said Saturday.
Cardiology Mar 24, 2012 | not rated yet | 0
Approval for a new dose of a best-selling Alzheimer's drug "breached the FDA's own regulatory standard" and has led to "incomplete and distorted messages" about the drug, warn experts in the British Medical Journal today. ...
Alzheimer's disease & dementia Mar 22, 2012 | 5 / 5 (1) | 0
Avastin, the blockbuster drug that just lost approval for treating breast cancer, now looks disappointing against ovarian cancer, too. Two studies found it did not improve survival for most of these patients and kept their ...
Cancer Dec 28, 2011 | 4.3 / 5 (4) | 1